retatrutide clinical trial phase safety trials A new clinical from Eli Lilly and Company suggests its experimental Lilly's triple agonist, retatrutide, delivered

A small study found that drugs like Ozempic, Wegovy, and Mounjaro change the way the body processes alcohol, making it less intoxicating.

This webinar with obesity medicine physician Jonathan Bonnet, MD, MPH, a GLP-1RA expert, will answer all your questions about the medications, how they work, their benefits, their side effects, and how they can be combined with lifestyle changes to optimize your weight loss and body composition.

Retatrutide, a first-in-class GIP, GLP-1 & Glucagon triple hormone receptor agonist drug leads to nearly 29% weight loss in first pivotal test

Erica P

It is mainly produced in enteroendocrine L cells of the gut and is secreted into the blood stream when food containing fat, protein hydrolysate and/or glucose enters the ...